Skip to content
Back Home
  • About
    • Our Team
    • Board of Directors
  • Technology
  • Applications
  • News & Media
  • Contact Us
Woman in Sunlit Field

​Pioneering Breakthrough Therapies

for Nervous System Disorders

About Us

Amorsa is dedicated to improving the health and well-being of patients affected by nervous system disorders.

Technology Platform

Building on ketamine's proven success as a rapid-acting antidepressant and potent analgesic, Amorsa is developing novel non-invasive therapeutic agents based on proprietary ketamine analogs.

Target Applications

Pioneering breakthrough treatments for nervous system disorders including treatment-resistant depression and moderate-to-severe pain.

Latest News

    February 14, 2019

    Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Deuterated Norketamine and Related Compounds

    June 1, 2018

    Amorsa Therapeutics Appoints Jeffrey Wiesen to Board of Directors

    January 9, 2018

    Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

Contact Us

  • info@amorsatx.com
  • Amorsa on LinkedIn
  • (508) 571-8240
  • 164 Cordaville Rd., Ste. 628​
    Southborough, MA 01772

Navigation

  • Home
  • Contact Us
  • News & Media
  • About
  • Technology
  • Applications
  • Board of Directors

· © 2020 Amorsa Therapeutics · Powered by · Designed with the Customizr theme ·